Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Denali Therapeutics (DNLI) Depreciation & Amortization (CF) (2017 - 2026)

Denali Therapeutics has reported Depreciation & Amortization (CF) over the past 9 years, most recently at $2.9 million for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 54.25% to $2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.2 million through Dec 2025, up 43.37% year-over-year, with the annual reading at $11.2 million for FY2025, 43.37% up from the prior year.
  • Depreciation & Amortization (CF) was $2.9 million for Q4 2025 at Denali Therapeutics, down from $2.9 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $10.0 million in Q1 2023 and troughed at $1.8 million in Q3 2024.
  • The 5-year median for Depreciation & Amortization (CF) is $2.2 million (2021), against an average of $2.7 million.
  • Year-over-year, Depreciation & Amortization (CF) skyrocketed 383.26% in 2023 and then crashed 78.48% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.1 million in 2021, then soared by 94.72% to $4.1 million in 2022, then crashed by 46.79% to $2.2 million in 2023, then fell by 14.65% to $1.9 million in 2024, then soared by 54.25% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for DNLI's Depreciation & Amortization (CF) are $2.9 million (Q4 2025), $2.9 million (Q3 2025), and $3.0 million (Q2 2025).